Three-Year Recurrence of Dupuytren Contracture after Needle Fasciotomy or Collagenase Injection: A Randomized Controlled Trial

Keyphrases

• Randomized Controlled Trial 100%
• Collagenase Injection 100%
• Percutaneous Needle Fasciotomy 100%
• Dupuytren's Contracture 100%
• Needle Fasciotomy 100%
• Collagenase Clostridium Histolyticum 83%
• Metacarpophalangeal Joint 33%
• Dupuytren's Disease 33%
• Joint Contracture 33%
• Recurrence Rate 16%
• Single Center 16%
• Randomized Controlled Clinical Trial 16%
• Serious Adverse Events 16%
• Further Treatment 16%
• Injection Therapy 16%
• Extension Deficit 16%
• Question Level 16%
• Xiapex 16%

Medicine and Dentistry

• Randomized Controlled Trial 100%
• Recurrent Disease 100%
• Collagenase 100%
• Fasciotomy 100%
• Dupuytren Contracture 100%
• Clostridiopeptidase A 75%
• Metacarpophalangeal Joint 25%
• Joint Contracture 25%
• Disease 12%
• Adverse Event 12%
• Recurrence Risk 12%
• Controlled Clinical Trial 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Randomized Controlled Trial 100%
• Recurrent Disease 100%
• Collagenase 100%
• Clostridiopeptidase A 100%
• Dupuytren Contracture 100%
• Joint Contracture 33%
• Disease 16%
• Adverse Event 16%
• Controlled Clinical Trial 16%
• Recurrence Risk 16%